Koyfin Home > Directory > Health Care > Amphastar Pharma > Repurchase of Common Stock

Amphastar Pharma Repurchase of Common Stock Chart (AMPH)

Amphastar Pharma annual/quarterly Repurchase of Common Stock from 2014 to 2018.
  • Amphastar Pharma Repurchase of Common Stock for the quarter ending September 09, 2018 was $-7m a 18.11% decrease of -1m year over year
  • Amphastar Pharma Repurchase of Common Stock for the last 12 months ending September 09, 2018 was $-28m a -8.21% increase of 2m year over year
  • Amphastar Pharma Annual Repurchase of Common Stock for 2017 was $-31m a 67.78% decrease of -21m from 2016
  • Amphastar Pharma Annual Repurchase of Common Stock for 2016 was $-10m a 0.43% decrease of 0m from 2015
  • Amphastar Pharma Annual Repurchase of Common Stock for 2015 was $-10m a 96.50% decrease of -10m from 2014
Other Cash Flow Metrics:
  • Amphastar Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $16m a 38.12% increase of 6m year over year
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 389.71% increase of 8m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Repurchase of Common Stock Data

09/2018$-7m
06/2018$-6m
03/2018$-9m
12/2017$-6m
09/2017$-8m
06/2017$-7m
03/2017$-10m
12/2016$-1m
09/2016$-1m
06/2016$-3m

Annual AMPH Repurchase of Common Stock Data

2017$-31m
2016$-10m
2015$-10m
2014$0m
2013$0m